eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case The GLP-1 drugs have favorable
Pay in 4 interest-free payments of $6.95 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case The GLP-1 drugs have favorable](https://substackcdn.com/image/fetch/$s_!q2fE!,f_auto,q_auto:best,fl_progressive:steep/https%3A%2F%2Ferictopol.substack.com%2Fapi%2Fv1%2Fpost_preview%2F138773822%2Ftwitter.jpg%3Fversion%3D4)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case The GLP-1 drugs have favorable](https://image.oaes.cc/published/article/59079b247e0ba663681516ae183312f7/and5022-coverimg.jpg)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case The GLP-1 drugs have favorable](https://www.agbt.org/wp-content/uploads/2020/06/topol-eric.jpg)






:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)















